Structure

Physi-Chem Properties

Molecular Weight:  382.11
Volume:  381.27
LogP:  3.067
LogD:  2.356
LogS:  -3.507
# Rotatable Bonds:  4
TPSA:  110.13
# H-Bond Aceptor:  7
# H-Bond Donor:  2
# Rings:  3
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.611
Synthetic Accessibility Score:  4.069
Fsp3:  0.19
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.206
MDCK Permeability:  2.1300702428561635e-05
Pgp-inhibitor:  0.011
Pgp-substrate:  0.01
Human Intestinal Absorption (HIA):  0.897
20% Bioavailability (F20%):  0.995
30% Bioavailability (F30%):  0.84

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.06
Plasma Protein Binding (PPB):  86.8814468383789%
Volume Distribution (VD):  1.071
Pgp-substrate:  8.86097240447998%

ADMET: Metabolism

CYP1A2-inhibitor:  0.969
CYP1A2-substrate:  0.483
CYP2C19-inhibitor:  0.825
CYP2C19-substrate:  0.124
CYP2C9-inhibitor:  0.844
CYP2C9-substrate:  0.607
CYP2D6-inhibitor:  0.913
CYP2D6-substrate:  0.116
CYP3A4-inhibitor:  0.876
CYP3A4-substrate:  0.274

ADMET: Excretion

Clearance (CL):  1.621
Half-life (T1/2):  0.885

ADMET: Toxicity

hERG Blockers:  0.062
Human Hepatotoxicity (H-HT):  0.956
Drug-inuced Liver Injury (DILI):  0.955
AMES Toxicity:  0.832
Rat Oral Acute Toxicity:  0.855
Maximum Recommended Daily Dose:  0.957
Skin Sensitization:  0.949
Carcinogencity:  0.75
Eye Corrosion:  0.003
Eye Irritation:  0.304
Respiratory Toxicity:  0.469

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC84142

Natural Product ID:  NPC84142
Common Name*:   (-)-Mitorubrin
IUPAC Name:   [(7R)-7-methyl-6,8-dioxo-3-[(E)-prop-1-enyl]isochromen-7-yl] 2,4-dihydroxy-6-methylbenzoate
Synonyms:   (-)-Mitorubrin
Standard InCHIKey:  ZLULUXWJVBHEMS-KTBYTZPXSA-N
Standard InCHI:  InChI=1S/C21H18O7/c1-4-5-14-7-12-8-17(24)21(3,19(25)15(12)10-27-14)28-20(26)18-11(2)6-13(22)9-16(18)23/h4-10,22-23H,1-3H3/b5-4+/t21-/m1/s1
SMILES:  C/C=C/C1=CC2=CC(=O)[C@](C)(C(=O)C2=CO1)OC(=O)c1c(C)cc(cc1O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1823114
PubChem CID:   6451554
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0003477] Azaphilones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO29948 Penicillium purpurogenum Species Trichocomaceae Eukaryota n.a. n.a. n.a. PMID[2010354]
NPO29948 Penicillium purpurogenum Species Trichocomaceae Eukaryota n.a. mycelium n.a. PMID[21879714]
NPO33444 penicillium pinophilum Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[22264170]
NPO33444 penicillium pinophilum Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[26291474]
NPO33693 Talaromyces aculeatus DS-62013 Species Trichocomaceae Eukaryota n.a. saline-alkali soil, Shandong Province, China 2013-APR PMID[28749670]
NPO29948 Penicillium purpurogenum Species Trichocomaceae Eukaryota n.a. n.a. n.a. PMID[32293887]
NPO5411 Talaromyces austrocalifornicus Species Trichocomaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT742 Organism Influenza A virus Influenza A virus IC50 > 200000.0 nM PMID[559338]
NPT1311 Organism Listonella anguillarum Listonella anguillarum MIC = 0.26 ug.mL-1 PMID[559340]
NPT20648 PROTEIN FAMILY Alpha glucosidase Homo sapiens IC50 > 200000.0 nM PMID[559340]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC84142 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.993 High Similarity NPC164762
0.9861 High Similarity NPC91809
0.9527 High Similarity NPC317585
0.9521 High Similarity NPC472891
0.94 High Similarity NPC472889
0.9396 High Similarity NPC208173
0.9396 High Similarity NPC170189
0.9396 High Similarity NPC478221
0.9396 High Similarity NPC472890
0.9392 High Similarity NPC76041
0.9392 High Similarity NPC115249
0.9392 High Similarity NPC184284
0.9392 High Similarity NPC478224
0.9329 High Similarity NPC137301
0.9296 High Similarity NPC52358
0.9272 High Similarity NPC478225
0.9267 High Similarity NPC69043
0.9267 High Similarity NPC478230
0.9216 High Similarity NPC317544
0.92 High Similarity NPC478231
0.9167 High Similarity NPC158634
0.9145 High Similarity NPC246466
0.9091 High Similarity NPC478200
0.9091 High Similarity NPC33144
0.9041 High Similarity NPC478202
0.9034 High Similarity NPC472035
0.9034 High Similarity NPC478201
0.9034 High Similarity NPC244923
0.9028 High Similarity NPC92655
0.9028 High Similarity NPC268052
0.9028 High Similarity NPC32360
0.902 High Similarity NPC478226
0.8993 High Similarity NPC73411
0.8993 High Similarity NPC215711
0.8966 High Similarity NPC156872
0.8958 High Similarity NPC191835
0.8944 High Similarity NPC175943
0.8933 High Similarity NPC77325
0.8933 High Similarity NPC4423
0.8926 High Similarity NPC210320
0.8919 High Similarity NPC472034
0.8904 High Similarity NPC478217
0.8904 High Similarity NPC53649
0.8904 High Similarity NPC313123
0.8889 High Similarity NPC70380
0.8873 High Similarity NPC153783
0.8868 High Similarity NPC328321
0.8859 High Similarity NPC472033
0.8851 High Similarity NPC475201
0.8851 High Similarity NPC151607
0.8851 High Similarity NPC42540
0.8851 High Similarity NPC126882
0.8851 High Similarity NPC210966
0.8851 High Similarity NPC478203
0.8844 High Similarity NPC474385
0.8836 High Similarity NPC158472
0.8831 High Similarity NPC472050
0.8828 High Similarity NPC472602
0.8828 High Similarity NPC177307
0.8828 High Similarity NPC9121
0.8828 High Similarity NPC212693
0.8828 High Similarity NPC94248
0.8824 High Similarity NPC471695
0.8819 High Similarity NPC235115
0.8805 High Similarity NPC283041
0.88 High Similarity NPC259632
0.88 High Similarity NPC472036
0.88 High Similarity NPC52106
0.8797 High Similarity NPC191930
0.8792 High Similarity NPC257558
0.8792 High Similarity NPC312789
0.8784 High Similarity NPC472006
0.8784 High Similarity NPC159721
0.8776 High Similarity NPC475730
0.8776 High Similarity NPC67650
0.8776 High Similarity NPC472603
0.8776 High Similarity NPC1704
0.8767 High Similarity NPC247409
0.8759 High Similarity NPC71256
0.8759 High Similarity NPC135837
0.875 High Similarity NPC56204
0.875 High Similarity NPC158866
0.875 High Similarity NPC295036
0.8742 High Similarity NPC240253
0.8742 High Similarity NPC240622
0.8742 High Similarity NPC471642
0.8742 High Similarity NPC20237
0.8742 High Similarity NPC471641
0.8742 High Similarity NPC37139
0.8734 High Similarity NPC249181
0.8733 High Similarity NPC51513
0.8733 High Similarity NPC202112
0.8732 High Similarity NPC219892
0.8732 High Similarity NPC189823
0.8725 High Similarity NPC277426
0.8725 High Similarity NPC86373
0.8725 High Similarity NPC280404
0.8725 High Similarity NPC210425
0.8716 High Similarity NPC250755
0.8707 High Similarity NPC472600
0.8707 High Similarity NPC49242
0.8707 High Similarity NPC472601
0.8707 High Similarity NPC155205
0.8701 High Similarity NPC472799
0.8699 High Similarity NPC472403
0.869 High Similarity NPC50455
0.8684 High Similarity NPC237440
0.8684 High Similarity NPC270160
0.8658 High Similarity NPC354984
0.8658 High Similarity NPC471731
0.8658 High Similarity NPC51106
0.8658 High Similarity NPC469542
0.8649 High Similarity NPC472605
0.8649 High Similarity NPC472604
0.8645 High Similarity NPC99381
0.8639 High Similarity NPC25427
0.8639 High Similarity NPC105456
0.8639 High Similarity NPC295339
0.8639 High Similarity NPC139634
0.863 High Similarity NPC474771
0.863 High Similarity NPC474849
0.863 High Similarity NPC178467
0.863 High Similarity NPC65837
0.863 High Similarity NPC194579
0.863 High Similarity NPC149372
0.8627 High Similarity NPC150928
0.8621 High Similarity NPC27407
0.8621 High Similarity NPC180905
0.8621 High Similarity NPC182496
0.8618 High Similarity NPC2569
0.8618 High Similarity NPC172329
0.8609 High Similarity NPC473023
0.8609 High Similarity NPC107625
0.8609 High Similarity NPC163846
0.8609 High Similarity NPC225173
0.86 High Similarity NPC470216
0.86 High Similarity NPC66404
0.86 High Similarity NPC95123
0.8591 High Similarity NPC49108
0.8591 High Similarity NPC469579
0.8591 High Similarity NPC471733
0.8591 High Similarity NPC82913
0.8581 High Similarity NPC210942
0.8581 High Similarity NPC109007
0.8581 High Similarity NPC169990
0.8581 High Similarity NPC230902
0.8571 High Similarity NPC475974
0.8571 High Similarity NPC61590
0.8571 High Similarity NPC46882
0.8571 High Similarity NPC230848
0.8571 High Similarity NPC132990
0.8562 High Similarity NPC10027
0.8562 High Similarity NPC476684
0.8562 High Similarity NPC158481
0.8562 High Similarity NPC474052
0.8562 High Similarity NPC65775
0.8553 High Similarity NPC473022
0.8553 High Similarity NPC125801
0.8543 High Similarity NPC474630
0.8543 High Similarity NPC83272
0.8543 High Similarity NPC28632
0.8543 High Similarity NPC134621
0.8535 High Similarity NPC263483
0.8533 High Similarity NPC472610
0.8533 High Similarity NPC215451
0.8533 High Similarity NPC277369
0.8526 High Similarity NPC56786
0.8526 High Similarity NPC80534
0.8523 High Similarity NPC90411
0.8523 High Similarity NPC37530
0.8516 High Similarity NPC470340
0.8516 High Similarity NPC271681
0.8514 High Similarity NPC88269
0.8506 High Similarity NPC470107
0.8506 High Similarity NPC85131
0.8503 High Similarity NPC476333
0.8503 High Similarity NPC472364
0.8503 High Similarity NPC473391
0.8503 High Similarity NPC301915
0.8503 High Similarity NPC261292
0.8503 High Similarity NPC472367
0.8497 Intermediate Similarity NPC153417
0.8497 Intermediate Similarity NPC221352
0.8497 Intermediate Similarity NPC211811
0.8493 Intermediate Similarity NPC142027
0.8491 Intermediate Similarity NPC117985
0.8487 Intermediate Similarity NPC196114
0.8487 Intermediate Similarity NPC237208
0.8487 Intermediate Similarity NPC153758
0.8487 Intermediate Similarity NPC470570
0.8483 Intermediate Similarity NPC43627
0.8481 Intermediate Similarity NPC470339
0.8477 Intermediate Similarity NPC193703
0.8477 Intermediate Similarity NPC257025
0.8477 Intermediate Similarity NPC184702
0.8477 Intermediate Similarity NPC21599
0.8472 Intermediate Similarity NPC198249
0.8472 Intermediate Similarity NPC470831
0.8472 Intermediate Similarity NPC214702
0.8467 Intermediate Similarity NPC136840

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC84142 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8767 High Similarity NPD970 Clinical (unspecified phase)
0.8462 Intermediate Similarity NPD7819 Suspended
0.8355 Intermediate Similarity NPD6799 Approved
0.8311 Intermediate Similarity NPD1510 Phase 2
0.8302 Intermediate Similarity NPD7075 Discontinued
0.8301 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8301 Intermediate Similarity NPD2534 Approved
0.8301 Intermediate Similarity NPD2532 Approved
0.8301 Intermediate Similarity NPD2533 Approved
0.8291 Intermediate Similarity NPD3817 Phase 2
0.8278 Intermediate Similarity NPD3750 Approved
0.8269 Intermediate Similarity NPD6599 Discontinued
0.8228 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8165 Intermediate Similarity NPD6801 Discontinued
0.8125 Intermediate Similarity NPD3882 Suspended
0.8054 Intermediate Similarity NPD1607 Approved
0.8041 Intermediate Similarity NPD1240 Approved
0.8039 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.8026 Intermediate Similarity NPD1549 Phase 2
0.8013 Intermediate Similarity NPD1512 Approved
0.8013 Intermediate Similarity NPD2796 Approved
0.7988 Intermediate Similarity NPD6232 Discontinued
0.7987 Intermediate Similarity NPD7411 Suspended
0.7963 Intermediate Similarity NPD3749 Approved
0.7962 Intermediate Similarity NPD5403 Approved
0.7961 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7961 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7952 Intermediate Similarity NPD7473 Discontinued
0.795 Intermediate Similarity NPD5402 Approved
0.7949 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7947 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7947 Intermediate Similarity NPD3748 Approved
0.7925 Intermediate Similarity NPD4380 Phase 2
0.7895 Intermediate Similarity NPD1551 Phase 2
0.7888 Intermediate Similarity NPD2801 Approved
0.7888 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7885 Intermediate Similarity NPD1511 Approved
0.7867 Intermediate Similarity NPD230 Phase 1
0.7834 Intermediate Similarity NPD5401 Approved
0.7829 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD1934 Approved
0.7818 Intermediate Similarity NPD6959 Discontinued
0.7806 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD7768 Phase 2
0.7784 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD2935 Discontinued
0.7765 Intermediate Similarity NPD6797 Phase 2
0.7746 Intermediate Similarity NPD9545 Approved
0.7744 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.773 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7719 Intermediate Similarity NPD7251 Discontinued
0.7697 Intermediate Similarity NPD919 Approved
0.7679 Intermediate Similarity NPD6166 Phase 2
0.7679 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7679 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7674 Intermediate Similarity NPD7808 Phase 3
0.7667 Intermediate Similarity NPD3764 Approved
0.7667 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD5710 Approved
0.7665 Intermediate Similarity NPD5711 Approved
0.7662 Intermediate Similarity NPD5406 Approved
0.7662 Intermediate Similarity NPD5404 Approved
0.7662 Intermediate Similarity NPD5408 Approved
0.7662 Intermediate Similarity NPD5405 Approved
0.7658 Intermediate Similarity NPD7390 Discontinued
0.7647 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD5844 Phase 1
0.764 Intermediate Similarity NPD3226 Approved
0.7628 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7628 Intermediate Similarity NPD2800 Approved
0.7606 Intermediate Similarity NPD9493 Approved
0.76 Intermediate Similarity NPD8150 Discontinued
0.7588 Intermediate Similarity NPD3818 Discontinued
0.7582 Intermediate Similarity NPD6651 Approved
0.7576 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD943 Approved
0.7548 Intermediate Similarity NPD6099 Approved
0.7548 Intermediate Similarity NPD6100 Approved
0.7544 Intermediate Similarity NPD7054 Approved
0.7532 Intermediate Similarity NPD6190 Approved
0.7516 Intermediate Similarity NPD1243 Approved
0.7516 Intermediate Similarity NPD920 Approved
0.75 Intermediate Similarity NPD2346 Discontinued
0.75 Intermediate Similarity NPD7472 Approved
0.7485 Intermediate Similarity NPD3751 Discontinued
0.7484 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD4628 Phase 3
0.745 Intermediate Similarity NPD1470 Approved
0.7415 Intermediate Similarity NPD1201 Approved
0.7414 Intermediate Similarity NPD6559 Discontinued
0.7399 Intermediate Similarity NPD7074 Phase 3
0.7391 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD2799 Discontinued
0.7365 Intermediate Similarity NPD9717 Approved
0.7361 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7356 Intermediate Similarity NPD5953 Discontinued
0.7356 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD1465 Phase 2
0.7337 Intermediate Similarity NPD5494 Approved
0.7333 Intermediate Similarity NPD1203 Approved
0.732 Intermediate Similarity NPD411 Approved
0.7312 Intermediate Similarity NPD7435 Discontinued
0.731 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD3926 Phase 2
0.7305 Intermediate Similarity NPD4288 Approved
0.7303 Intermediate Similarity NPD6832 Phase 2
0.7301 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD422 Phase 1
0.7294 Intermediate Similarity NPD1247 Approved
0.7285 Intermediate Similarity NPD2798 Approved
0.7278 Intermediate Similarity NPD2344 Approved
0.7261 Intermediate Similarity NPD4308 Phase 3
0.7261 Intermediate Similarity NPD7033 Discontinued
0.7251 Intermediate Similarity NPD3787 Discontinued
0.7241 Intermediate Similarity NPD7286 Phase 2
0.7222 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD3268 Approved
0.7208 Intermediate Similarity NPD2313 Discontinued
0.7207 Intermediate Similarity NPD8434 Phase 2
0.7181 Intermediate Similarity NPD8319 Approved
0.7181 Intermediate Similarity NPD8320 Phase 1
0.7179 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7179 Intermediate Similarity NPD447 Suspended
0.7178 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7175 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7174 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD1471 Phase 3
0.716 Intermediate Similarity NPD3300 Phase 2
0.716 Intermediate Similarity NPD7236 Approved
0.7158 Intermediate Similarity NPD6534 Approved
0.7158 Intermediate Similarity NPD6535 Approved
0.7151 Intermediate Similarity NPD6778 Approved
0.7151 Intermediate Similarity NPD6781 Approved
0.7151 Intermediate Similarity NPD6782 Approved
0.7151 Intermediate Similarity NPD6780 Approved
0.7151 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7151 Intermediate Similarity NPD6779 Approved
0.7151 Intermediate Similarity NPD6777 Approved
0.7151 Intermediate Similarity NPD6776 Approved
0.7143 Intermediate Similarity NPD7003 Approved
0.7143 Intermediate Similarity NPD8166 Discontinued
0.7133 Intermediate Similarity NPD9269 Phase 2
0.7115 Intermediate Similarity NPD4060 Phase 1
0.7108 Intermediate Similarity NPD7458 Discontinued
0.7105 Intermediate Similarity NPD1164 Approved
0.7105 Intermediate Similarity NPD2797 Approved
0.7099 Intermediate Similarity NPD2309 Approved
0.7095 Intermediate Similarity NPD9268 Approved
0.7093 Intermediate Similarity NPD7199 Phase 2
0.7086 Intermediate Similarity NPD4749 Approved
0.7083 Intermediate Similarity NPD37 Approved
0.7083 Intermediate Similarity NPD7874 Approved
0.7083 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD2654 Approved
0.7076 Intermediate Similarity NPD6234 Discontinued
0.707 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.707 Intermediate Similarity NPD5124 Phase 1
0.7069 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD4967 Phase 2
0.7059 Intermediate Similarity NPD4965 Approved
0.7059 Intermediate Similarity NPD4966 Approved
0.7052 Intermediate Similarity NPD7229 Phase 3
0.7047 Intermediate Similarity NPD4626 Approved
0.7044 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7043 Intermediate Similarity NPD7699 Phase 2
0.7043 Intermediate Similarity NPD7700 Phase 2
0.7042 Intermediate Similarity NPD74 Approved
0.7042 Intermediate Similarity NPD9266 Approved
0.7039 Intermediate Similarity NPD8312 Approved
0.7039 Intermediate Similarity NPD8313 Approved
0.7037 Intermediate Similarity NPD7696 Phase 3
0.7037 Intermediate Similarity NPD7698 Approved
0.7037 Intermediate Similarity NPD7697 Approved
0.7033 Intermediate Similarity NPD4287 Approved
0.7032 Intermediate Similarity NPD4625 Phase 3
0.703 Intermediate Similarity NPD6273 Approved
0.702 Intermediate Similarity NPD1608 Approved
0.702 Intermediate Similarity NPD3972 Approved
0.7014 Intermediate Similarity NPD1609 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD4307 Phase 2
0.7 Intermediate Similarity NPD7871 Phase 2
0.7 Intermediate Similarity NPD7870 Phase 2
0.6989 Remote Similarity NPD7177 Discontinued
0.6987 Remote Similarity NPD6798 Discontinued
0.6987 Remote Similarity NPD6410 Clinical (unspecified phase)
0.698 Remote Similarity NPD5691 Approved
0.6977 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6972 Remote Similarity NPD9263 Approved
0.6972 Remote Similarity NPD9267 Approved
0.6972 Remote Similarity NPD9264 Approved
0.6972 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6971 Remote Similarity NPD2403 Approved
0.6968 Remote Similarity NPD4908 Phase 1
0.6962 Remote Similarity NPD6355 Discontinued
0.6948 Remote Similarity NPD1019 Discontinued
0.6946 Remote Similarity NPD7239 Suspended

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data